I'm headed to Philadelphia, where my doctor is located (I'm in New Jersey) to start my new treatment regimen of Stelara. To say I'm not looking forward to it is an understatement. Stelara was approved for the treatment of Crohn's disease only about a month ago. Before that, an injection regimen of the drug was used very well in psoriatic arthritis patients. (Interestingly, my husband has psoriatic arthritis but he doesn't use Stelara.) The Stelara regimen for Crohn's disease starts with an hour-long infusion in the infusion center (and I know how it goes — between the set-up and the monitoring before and after the infusion, I will be there for much longer than an hour), followed by a shot at home every eight weeks. There's about a 34 percent chance that a patient will go into remission, and the remission could take almost a year to achieve. Unless you're someone like me. Since I was diagnosed 15 years ago — and had symptoms for much longer than that — and have used so many different treatments, the chances that I'll go into remission are much lower. My doctor refuses to give me odds, except to acknowledge it's not nearly as likely as unlikely. Still, we have to try.